APA (7th ed.) Citation

M, U., F, V., L, R., E, K., R, S., S, B., . . . J, S. (2025). Aurora kinase A inhibition as a synthetic lethality strategy in ARID1A-mutated gastroenteropancreatic neuroendocrine carcinoma. Cancer letters, 634, 218033. https://doi.org/10.1016/j.canlet.2025.218033

Chicago Style (17th ed.) Citation

M, Urbanova, et al. "Aurora Kinase A Inhibition as a Synthetic Lethality Strategy in ARID1A-mutated Gastroenteropancreatic Neuroendocrine Carcinoma." Cancer Letters 634 (2025): 218033. https://doi.org/10.1016/j.canlet.2025.218033.

MLA (9th ed.) Citation

M, Urbanova, et al. "Aurora Kinase A Inhibition as a Synthetic Lethality Strategy in ARID1A-mutated Gastroenteropancreatic Neuroendocrine Carcinoma." Cancer Letters, vol. 634, 2025, p. 218033, https://doi.org/10.1016/j.canlet.2025.218033.